Understanding how myeloid cells can hide HIV-1 from treatment

Irreversible Proviral Silencing in Myeloid Cells

['FUNDING_R21'] · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · NIH-10897903

This study is looking at how certain immune cells can keep the HIV-1 virus hidden in people who are on treatment, and it aims to find new ways to help get rid of the virus for good.

Quick facts

Phase['FUNDING_R21']
Study typeNih_funding
SexAll
SponsorUNIVERSITY OF MIAMI SCHOOL OF MEDICINE (nih funded)
Locations1 site (CORAL GABLES, UNITED STATES)
Trial IDNIH-10897903 on ClinicalTrials.gov

What this research studies

This research investigates how certain immune cells, specifically myeloid cells, can harbor the HIV-1 virus even in patients receiving effective antiretroviral therapy (ART). The team aims to create a model to study the latency of the virus in these cells, focusing on how specific cellular mechanisms can lead to the virus remaining undetected and persistent. By examining the role of NF-kB inhibition, the researchers hope to uncover new insights into the epigenetic changes that allow the virus to evade treatment. This could lead to innovative strategies for eliminating HIV-1 from the body.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals living with HIV-1 who are currently on effective ART and have experienced viral rebound.

Not a fit: Patients who are not infected with HIV-1 or those who are not on ART may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new therapies that effectively eliminate HIV-1 from patients, potentially curing the infection.

How similar studies have performed: Previous research has shown that targeting viral reservoirs in immune cells can lead to significant advancements in HIV treatment, indicating that this approach has potential for success.

Where this research is happening

CORAL GABLES, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.